Dr. Schneider CV

CURRICULUM VITAE OF ANDREW M. SCHNEIDER, MD

MEDICAL SPECIALTY:
Medical Oncology and Hematology

EDUCATION:
Brandies University, Waltham, MA
BA, Biochemistry , 1976 – 1980

MEDICAL EDUCATION:
SUNY Buffalo School of Medicine, Buffalo, NY
Doctor of Medicine, 1980 – 1984

POSTDOCTORAL TRAINING:
Montefiore Medical Center, Bronx, NY
Internship and Residency in Internal Medicine,
July 1984 – June 1987

Memorial Sloan-Kettering Cancer Center, New York, NY
Fellowship in Hematology and Medical Oncology,
July 1987 – June 1989

BOARD CERTIFICATION:
American Board of Internal Medicine, 1987
Medical Oncology, 1989
Hospice and Palliative Care, 1998

LICENSURE:
Florida:
ME 55189

HOSPITAL AFFILIATIONS AND APPOINTMENTS:
Florida Medical Center, Fort Lauderdale, FL
Staff Physician, 1989 – Present

Westside Regional Medical Center, Plantation, FL
Staff Physician, 1989 – Present

Plantation General Hospital, Plantation, FL
Staff Physician, 1989 – Present

University Hospital and Medical Center, Tamarac, FL
Staff Physician, 1989 – Present

Northwest Medical Center, Lauderdale Lakes, FL
Staff Physician, 1989 – Present

Coral Springs Medical Center, Coral Springs, FL
Staff Physician, 1989 – Present

PROFESSIONAL AFFILIATIONS:
American College of Physicians

EXPERIENCE:
Infinity Clinical Research, LLC
Northshore Medical Center – FMC Campus
Clinical Research Unit, 4 West
5000 West Oakland Park Boulevard
Fort Lauderdale, FL 33313
Clinical Research Investigator, November 2012 – Present

Infinity Clinical Research, LLC
Research Headquarters
4925 Sheridan Street, Suite 200
Hollywood, FL 33021
Clinical Research Investigator, November 2012 – Present

Abrams & Schneider, MD, PA
7351 West Oakland Park Boulevard, Suite 101
Lauderhill, FL 33319
Medical Oncologist, 1989 – Present

South Florida Oncology & Hematology Consultants
4850 West Oakland Park Boulevard, Suite C
Fort Lauderdale, FL 33313
Medical Oncologist and Director of Laboratory, 1995 – Present

Northshore Medical Center – FMC Campus
5000 West Oakland Park Boulevard
Fort Lauderdale, FL 33313
Physician Liaison, Cancer Center, 1996 – Present
Quality Assurance Reviewer for Encompass, 1998 – Present

AWARDS:
Phi Beta Kappa, 1980
Brandeis University, Waltham, MA

Alpha Omega Alpha, 1984
SUNY Buffalo, NY

PUBLICATIONS:

Seiter, K., Kemeny, N., Martin, D., Schneider, A.: “Uridine allows dose escalation of 5-FU when given with N-Phosphonacetyl-L-Aspartate, Methotrexate and Leukovorin.” Cancer 71(5) 1875-1881, 1993

Schneider, A., Kemeny, N., et al: “Intrahepatic mitomycin-C as a salvage treatment for patients with hepatic metastasis from Colorectal cancer.” Cancer 64 (11) 2203-6, 1989

Kemeny, N., Schneider, A.: “Regional treatment of hepatic metastasis and hepatocellular carcinoma.” Current Problems Cancer 13 (4) 197-283, 1989

Kemeny, N., Schneider, A.: “Phase 1 trial of N-Phosphonacetyl-L-aspartate, Methotrexate and 5-FU with Leukovorin rescue in patients with advanced cancer.”

Bosl, G., Schneider, A., Pfister, D.: “Systemic therapy of Salivary Gland Neoplasms in Management of Salivary Gland Lesions”, edited by Mark Gronick, pp. 230-240 Williams and Wilkins, 1992

RESEARCH EXPERIENCE LIST PROVIDED UPON REQUEST